Definitions
Sorry, no definitions found. You may find more data at epoetin.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Epoetin.
Examples
-
Epoetin alfa was approved in 1989 by the Food and Drug Administration
-
Epoetin alfa was approved in 1989 by the Food and Drug Administration
-
Findings from an interim analysis of a new study comparing the hemoglobin response rates of Epoetin ...
THE MEDICAL NEWS Editors 2010
-
Perisurgery: EPOGEN®/PROCRIT®(Epoetin alfa) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation.
-
Epoetin alfa, which belongs to a class of drugs known as erythropoiesis-stimulating agents or ESA, is a bioengineered form of a protein made in the kidneys that is critical to red-blood cell production ESAs are approved in the US to treat anemia in patients with kidney disease and HIV, and cancer patients with chemotherapy-induced anemia.
-
Epoetin alfa, which belongs to a class of drugs known as erythropoiesis-stimulating agents or ESA, is a bioengineered form of a protein made in the kidneys that is critical to red-blood cell production ESAs are approved in the US to treat anemia in patients with kidney disease and HIV, and cancer patients with chemotherapy-induced anemia.
-
Depending on the country in which Epoetin alfa is marketed, these indications may differ.
-
Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include PROCRIT® (Epoetin alfa), Aranesp®
-
Epoetin alfa, which belongs to a class of drugs known as erythropoiesis-stimulating agents or ESA, is a bioengineered form of a protein made in the kidneys that is critical to red-blood cell production ESAs are approved in the US to treat anemia in patients with kidney disease and HIV, and cancer patients with chemotherapy-induced anemia.
-
Epoetin alfa, which belongs to a class of drugs known as erythropoiesis-stimulating agents or ESA, is a bioengineered form of a protein made in the kidneys that is critical to red-blood cell production ESAs are approved in the US to treat anemia in patients with kidney disease and HIV, and cancer patients with chemotherapy-induced anemia.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.